These final results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two assist the concept of concentrating on ACKR3 as a novel method to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant disorders. Once in a while https://williamc925jgc5.wikicommunications.com/user